Newcastle University spin out, Newcells Biotech are experts in building functional in vitro models to improve clinical translation and drug discovery. As well as this, they provide clients with validated in vitro tools to understand how drugs interact with tissues, and enable the generation of robust and informative data to support critical decisions during any stage of drug-development.

Watch as Co-founder and CEO, Mike Nicholds and Associate Director, Valeria Chichagova explain a little more about this disruptive technology and it’s rapid growth.